2019 International Congress » Functional (Psychogenic) Movement Disorders
Date: Monday, September 23, 2019
Time: 1:45pm-3:15pm
Location: Les Muses Terrace, Level 3
Meeting: 2019 International Congress
- 1:45pm-3:15pm
-
Altered intrinsic power spectral density of the precuneus in patients with hyperkinetic functional movement disorders
- 1:45pm-3:15pm
-
Botulinum Neurotoxin (BoNT) treatment in functional movement disorders: an extended follow up
- 1:45pm-3:15pm
-
Clinical spectrum of Functional Movement Disorders: A clinic based study from a developing country
- 1:45pm-3:15pm
-
Functional exam findings in Lewy Body Disease
- 1:45pm-3:15pm
-
FUNCTIONAL MOTOR SYMPTOMS IN PARKINSON’S DISEASE, AND FUNCTIONAL PARKINSONISM: A SYSTEMATIC REVIEW
- 1:45pm-3:15pm
-
Healthcare utilization and emergency department/inpatient costs in adult and pediatric functional neurological disorders
- 1:45pm-3:15pm
-
Incongruity of Functional Tremor Predicts Better Response to Transcranial Magnetic Stimulation Treatment
- 1:45pm-3:15pm
-
Long Term Follow Up Following Multidisciplinary Inpatient Rehabilitation for Functional Movement Disorders
- 1:45pm-3:15pm
-
Management of Patients with Functional Movement Disorders: A Transcultural Perspective
- 1:45pm-3:15pm
-
Preoperative quantitative evaluation of psychological determinants in abnormal head postures
- 1:45pm-3:15pm
-
rTMS-induced effects on Functional Tremor: a randomized, double-blind, controlled study
- 1:45pm-3:15pm
-
The effect of intranasal oxytocin in patients with functional motor symptoms: an open label case series
- 1:45pm-3:15pm
-
The role of attention in functional movement disorders